ES2570760T3 - Biogel - Google Patents

Biogel

Info

Publication number
ES2570760T3
ES2570760T3 ES07824729T ES07824729T ES2570760T3 ES 2570760 T3 ES2570760 T3 ES 2570760T3 ES 07824729 T ES07824729 T ES 07824729T ES 07824729 T ES07824729 T ES 07824729T ES 2570760 T3 ES2570760 T3 ES 2570760T3
Authority
ES
Spain
Prior art keywords
fibrinogen
molecules
binding peptides
vehicle
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07824729T
Other languages
English (en)
Inventor
Greg Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haemostatix Ltd
Original Assignee
Haemostatix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haemostatix Ltd filed Critical Haemostatix Ltd
Application granted granted Critical
Publication of ES2570760T3 publication Critical patent/ES2570760T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)

Abstract

Un biogel que comprende moléculas de fibrinógeno y una pluralidad de vehículos solubles, donde cada vehículo tiene una pluralidad de péptidos de unión a fibrinógeno inmovilizados en el vehículo, donde cada péptido de unión a fibrinógeno comprende la secuencia de aminoácidos NH2-G (P, H) RX- (SEQ ID NO: 15) en su extremo amino terminal, donde X es cualquier aminoácido, y (P,H) significa que o bien prolina o histidina están presentes en esa posición, y cada molécula de fibrinógeno está unida a al menos dos péptidos de unión a fibrinógeno, de modo que las moléculas de fibrinógeno están unidas entre sí a través de los vehículos mediante enlaces no covalentes entre los péptidos de unión a fibrinógeno y las moléculas de fibrinógeno.
ES07824729T 2006-11-27 2007-11-27 Biogel Active ES2570760T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0623607.9A GB0623607D0 (en) 2006-11-27 2006-11-27 Tissue adhesive
PCT/GB2007/004538 WO2008065388A2 (en) 2006-11-27 2007-11-27 Biogel

Publications (1)

Publication Number Publication Date
ES2570760T3 true ES2570760T3 (es) 2016-05-20

Family

ID=37636565

Family Applications (2)

Application Number Title Priority Date Filing Date
ES16155589T Active ES2896053T3 (es) 2006-11-27 2007-11-27 Biogel
ES07824729T Active ES2570760T3 (es) 2006-11-27 2007-11-27 Biogel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES16155589T Active ES2896053T3 (es) 2006-11-27 2007-11-27 Biogel

Country Status (13)

Country Link
US (2) US9339584B2 (es)
EP (2) EP2099505B1 (es)
JP (2) JP5801994B2 (es)
CN (1) CN101687061B (es)
AU (1) AU2007327100B2 (es)
CA (1) CA2669738C (es)
DK (1) DK2099505T3 (es)
ES (2) ES2896053T3 (es)
GB (1) GB0623607D0 (es)
IL (1) IL198699A (es)
PL (1) PL2099505T3 (es)
RU (1) RU2503464C2 (es)
WO (1) WO2008065388A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8623336B2 (en) 2008-12-15 2014-01-07 Council Of Scientific & Industrial Research Transparent xyloglucan/chitosan gel and a process for the preparation thereof
AU2011260258B2 (en) * 2010-06-01 2015-07-09 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
GB201101740D0 (en) 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding
GB201201751D0 (en) * 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
MX356867B (es) * 2012-12-07 2018-06-18 Baxter Healthcare Sa Espuma hemostatica.
IL230151A0 (en) * 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
GB201400292D0 (en) 2014-01-08 2014-02-26 Haemostatix Ltd Peptide dendrimers and agents
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
EA028039B1 (ru) * 2014-09-05 2017-09-29 Частное Учреждение Лаборатория Биотехнологических Исследований "3Д Биопринтинг Солюшенс" Устройство и способы печати биологических тканей и органов
IL235751A0 (en) * 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
GB201508024D0 (en) 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions
GB201508014D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic device
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
CN107432955B (zh) * 2016-09-14 2020-09-04 四川蓝光英诺生物科技股份有限公司 用于制备生物构建体的方法和试剂盒
BR112019006932A2 (pt) 2016-10-06 2019-07-02 Matoke Holdings Limited composições antimicrobianas
WO2018065789A1 (en) 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
JP7431172B2 (ja) 2018-04-23 2024-02-14 ダニスコ・ユーエス・インク ホスホリラーゼ酵素を用いたβ－１，３グリコシド結合を含むグルカンの合成
CN110448719B (zh) * 2019-06-28 2020-05-22 浙江大学 一种促进凝血的丝素-多肽电纺膜及其制备方法
US20230105440A1 (en) * 2021-10-06 2023-04-06 Medtronic, Inc. Anti-thrombogenic coating

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3171072D1 (en) 1981-06-25 1985-07-25 Stroetmann M Serapharm Enriched plasma derivative for promoting wound sealing and wound covering
US5357042A (en) 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
US5635477A (en) 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
IL103252A (en) 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU2096415C1 (ru) * 1991-09-30 1997-11-20 Дзе Дюпон Мерк Фармасьютикал Компани Циклические пептиды или их фармацевтически приемлемые соли, фармацевтическая композиция
FI954556A0 (fi) 1993-03-29 1995-09-26 Du Pont Merck Pharma Syklisiä yhdisteitä, jotka ovat käyttökelpoisia verihiutaleen glykoproteiinin IIb/IIIa inhibiittoreina
WO1995029686A1 (en) 1994-05-02 1995-11-09 E.R. Squibb & Sons, Inc. Recombinant fibrin chains, fibrin and fibrin-homologs
AU717906B2 (en) * 1994-12-07 2000-04-06 American National Red Cross, The Supplemented and unsupplemented tissue sealants, methods of their production and use
HUT77369A (hu) 1994-12-16 1998-03-30 Andaris Limited Keresztkötéses mikrorészecskék és felhasználásuk gyógyászati célú hordozóként
JPH11507630A (ja) 1995-06-06 1999-07-06 ヘモスフィアー，インコーポレイテッド 治療および診断用途のためのタンパク質粒子
WO1997044015A1 (en) 1996-05-17 1997-11-27 Andaris Limited Microparticles and their use in wound therapy
ATE284714T1 (de) 1996-10-21 2005-01-15 Quadrant Drug Delivery Ltd Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren
GB9724143D0 (en) 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
DE19849589C1 (de) * 1998-10-27 2000-06-15 Glatt Process Technology Gmbh Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung
EP1296724A1 (en) 2000-06-22 2003-04-02 Sam L. Austin Bioadhesive composition and methods of preparation and use
AR032517A1 (es) 2001-01-25 2003-11-12 Nycomed Pharma As Un metodo para preparar una esponja de colageno, un dispositivo para extraer una parte de una espuma de colageno, y una esponja de colageno alargada
CA2473727A1 (en) * 2001-12-04 2003-06-12 Christopher J. Woolverton Storage-stable fibrin sealant
EP1329438B1 (en) * 2002-01-14 2009-04-08 "VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK", afgekort "V.I.T.O." Method for producing metallic and ceramic products
AU2003226265A1 (en) * 2002-04-05 2003-10-27 Baxter Healthcare S.A. Storage stable liquid sealer protein complex
CA2482856A1 (en) 2002-04-15 2003-10-30 American National Red Cross Plasma protein-binding ligands
WO2004045494A2 (en) 2002-11-20 2004-06-03 Bar-Ilan University Biological glue based on thrombin-conjugated nanoparticles
KR101077805B1 (ko) 2003-05-08 2011-10-28 카네카 코포레이션 전혈 처리가 가능한 저밀도 리포 단백 및 피브리노겐의 흡착재, 및 흡착기
AU2004253463B2 (en) 2003-06-16 2010-12-09 Loma Linda University Medical Center Deployable multifunctional hemostatic agent
US7129210B2 (en) * 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
CN1544098A (zh) * 2003-11-12 2004-11-10 邹金生 高效神经生长因子生物胶及其制备和使用方法
WO2005076827A2 (en) * 2004-02-04 2005-08-25 Universita' Degli Studi Di Pavia Fbsa compositions for use in promoting fibrinogen aggregation and potentiating fibrin polymerization
US7833978B2 (en) * 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
US20060034935A1 (en) 2004-07-22 2006-02-16 Pronovost Allan D Compositions and methods for treating excessive bleeding
CN102091347A (zh) 2004-10-20 2011-06-15 伊西康公司 可吸收的止血物
GB0516091D0 (en) * 2005-08-04 2005-09-14 Haemostatix Ltd Therapeutic agent

Also Published As

Publication number Publication date
EP3095468B1 (en) 2021-08-11
IL198699A (en) 2014-12-31
DK2099505T3 (en) 2016-05-30
WO2008065388A2 (en) 2008-06-05
ES2896053T8 (es) 2022-03-03
US9339584B2 (en) 2016-05-17
AU2007327100A1 (en) 2008-06-05
JP2010510818A (ja) 2010-04-08
CN101687061A (zh) 2010-03-31
PL2099505T3 (pl) 2016-08-31
US20160287659A1 (en) 2016-10-06
US20100249044A1 (en) 2010-09-30
US9913876B2 (en) 2018-03-13
RU2503464C2 (ru) 2014-01-10
JP2013188550A (ja) 2013-09-26
EP2099505B1 (en) 2016-02-17
ES2896053T3 (es) 2022-02-23
CA2669738A1 (en) 2008-06-05
CN101687061B (zh) 2013-03-27
HK1231419A1 (en) 2017-12-22
JP5801994B2 (ja) 2015-10-28
WO2008065388A3 (en) 2009-11-26
RU2009119257A (ru) 2011-01-10
EP3095468A1 (en) 2016-11-23
IL198699A0 (en) 2010-02-17
AU2007327100B2 (en) 2014-03-06
EP2099505A2 (en) 2009-09-16
CA2669738C (en) 2017-05-30
GB0623607D0 (en) 2007-01-03

Similar Documents

Publication Publication Date Title
AR057614A1 (es) Composiciones y metodos para producir moleculas de union con antigeno hibridas y usos de las mismas
BRPI0512396A (pt) polipeptìdeos biossintéticos utilizando aminoácidos codificados não naturalmente
HRP20030948B1 (hr) Taci-imunoglobulin fuzijski proteini
PL1966240T6 (pl) Peptydy laktoferyny użyteczne jako peptydy penetrujące komórkę
NO20063026L (no) Antistoffer
UA98295C2 (ru) Опухолево-ассоциированный пептид, который неспецифически связывается с молекулами ii класса лейкоцитарного антигена человека (hla)
EP2322552A3 (en) IL-1beta binding antibodies and fragments thereof
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
WO2005017205A3 (en) Nucleic acid mapping using linear analysis
ATE535547T1 (de) Vernetzte antikörper
DK3085783T3 (da) Bispecifikt antistof som substitution for funktionelle proteiner
NZ616761A (en) Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
WO2011101681A3 (en) Disulphide bond-stabilized functional soluble mhc class ii heterodimers
WO2009004315A8 (en) Isolated peptides and uses thereof
WO2005053618A3 (en) Synthetic hla binding peptide analogues and uses thereof
AR066311A1 (es) Moleculas de anticuerpos anti proteina hsp90 fungica y acidos nucleicos que los codifican
ATE496943T1 (de) Biotinylierte mhc-komplexe und ihre verwendungen
DE69813099D1 (de) System zur Überwachung des Spannungszustandes von Hochdruckflaschen, insbesondere Methangasflaschen für Kraftfahrzeugen
BR0014860A (pt) Métodos para a produção de uma molécula alvo em um animal transgênico e purificação da molécula alvo
WO2004029072A3 (en) PrPsc -INTERACTING MOLECULES AND USES THEREOF
DE60129137D1 (de) Modulierung durch il-tif/interleukin-21
ATE474741T1 (de) Halterung für eine scheinwerfereinheit, verfahren zur deren herstellung und fronteinheit
ATE417056T1 (de) Verfahren zur proteinreinigung
WO2003050283A3 (en) A structure for presenting desired peptide sequences
BR0309279A (pt) Macromoléculas em multicamadas e métodos para uso das mesmas